AAAAAA

   
Results: 1-11 |
Results: 11
Immunosuppressive treatment of ocular myasthenia gravis
Authors: Tackenberg, B Hemmer, B Oertel, WH Sommer, N
Citation: B. Tackenberg et al., Immunosuppressive treatment of ocular myasthenia gravis, BIODRUGS, 15(6), 2001, pp. 369-378
New approaches to dissect degeneracy and specificity in T cell antigen recognition
Authors: Jacobsen, M Cepok, S Oertel, WH Sommer, N Hemmer, B
Citation: M. Jacobsen et al., New approaches to dissect degeneracy and specificity in T cell antigen recognition, J MOL MED-J, 79(7), 2001, pp. 358-367
New strategies for the treatment of multiple sclerosis
Authors: Hemmer, B Cepok, S Nessler, S Sommer, N
Citation: B. Hemmer et al., New strategies for the treatment of multiple sclerosis, MED KLIN, 96, 2001, pp. 23-28
No association of three polymorphisms in the alpha-2-macroglobulin and lipoprotein related receptor genes with multiple sclerosis
Authors: Schweer, D Jacobsen, M Ziegler, A Jakel, S Oertel, WH Sommer, N Hemmer, B
Citation: D. Schweer et al., No association of three polymorphisms in the alpha-2-macroglobulin and lipoprotein related receptor genes with multiple sclerosis, J NEUROIMM, 118(2), 2001, pp. 300-303
Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-A(S)
Authors: Kalbus, M Fleckenstein, BT Offenhausser, M Bluggel, M Melms, A Meyer, HE Rammensee, HG Martin, R Jung, G Sommer, N
Citation: M. Kalbus et al., Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-A(S), EUR J IMMUN, 31(2), 2001, pp. 551-562
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis
Authors: Cepok, S Jacobsen, M Schock, S Omer, B Jaekel, S Boddeker, I Oertel, WH Sommer, N Hemmer, B
Citation: S. Cepok et al., Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis, BRAIN, 124, 2001, pp. 2169-2176
T4 early promoter strength probed in vivo with unribosylated and ADP-ribosylated Escherichia coli RNA polymerase: a mutation analysis
Authors: Sommer, N Salniene, V Gineikiene, E Nivinskas, R Ruger, W
Citation: N. Sommer et al., T4 early promoter strength probed in vivo with unribosylated and ADP-ribosylated Escherichia coli RNA polymerase: a mutation analysis, MICROBIO-UK, 146, 2000, pp. 2643-2653
A point mutation in PTPRC is associated with the development of multiple sclerosis
Authors: Jacobsen, M Schweer, D Ziegler, A Gaber, R Schock, S Schwinzer, R Wonigeit, K Lindert, RB Kantarci, O Schaefer-Klein, J Schipper, HI Oertel, WH Heidenreich, F Weinshenker, BG Sommer, N Hemmer, B
Citation: M. Jacobsen et al., A point mutation in PTPRC is associated with the development of multiple sclerosis, NAT GENET, 26(4), 2000, pp. 495-499
Treatment of arterial hypertension with diuretics, beta- and calcium channel blockers in old patients
Authors: Nikolaus, T Sommer, N Becker, C
Citation: T. Nikolaus et al., Treatment of arterial hypertension with diuretics, beta- and calcium channel blockers in old patients, Z GERON GER, 33(6), 2000, pp. 427-432
Degeneracy in T-cell antigen recognition - implications for the pathogenesis of autoimmune diseases
Authors: Hemmer, B Jacobsen, M Sommer, N
Citation: B. Hemmer et al., Degeneracy in T-cell antigen recognition - implications for the pathogenesis of autoimmune diseases, J NEUROIMM, 107(2), 2000, pp. 148-153
Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor V beta analysis
Authors: Muraro, PA Jacobsen, M Necker, A Nagle, JW Gaber, R Sommer, N Oertel, WH Martin, R Hemmer, B
Citation: Pa. Muraro et al., Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor V beta analysis, J IMMUNOL M, 246(1-2), 2000, pp. 131-143
Risultati: 1-11 |